Revance Therapeutics Stock (RVNC)
Track Revance Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
RVNC
Revance Therapeutics
$3.65
▼ -1.45 (-28.43%) past year
Market Cap
—
P/E Ratio
—
1Y Return
-28.43%
EPS (TTM)
—
Read the latest TheStreet Pro articles mentioning Revance Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning RVNC yet.
Daily Diary Mentions
0 mentionsNo diary mentions for RVNC yet.